Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Harini Bagavant and Umesh Deshmukh.
Connection Strength

9.446
  1. Antibody deposition on vascular endothelial cells contributes to localized inflammation in salivary glands. J Oral Pathol Med. 2022 Aug; 51(7):674-677.
    View in: PubMed
    Score: 0.839
  2. Systemic immune response to vimentin and granuloma formation in a model of pulmonary sarcoidosis. J Transl Autoimmun. 2022; 5:100153.
    View in: PubMed
    Score: 0.823
  3. Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies. Front Immunol. 2021; 12:635072.
    View in: PubMed
    Score: 0.776
  4. Protocols for Experimental Sjögren's Syndrome. Curr Protoc Immunol. 2020 12; 131(1):e114.
    View in: PubMed
    Score: 0.750
  5. The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned. Autoimmun Rev. 2020 Dec; 19(12):102686.
    View in: PubMed
    Score: 0.745
  6. Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients. Clin Exp Rheumatol. 2019 Jan-Feb; 37(1):106-111.
    View in: PubMed
    Score: 0.634
  7. A Method for the Measurement of Salivary Gland Function in Mice. J Vis Exp. 2018 01 25; (131).
    View in: PubMed
    Score: 0.616
  8. Alum, an aluminum-based adjuvant, induces Sjögren's syndrome-like disorder in mice. Clin Exp Rheumatol. 2014 Mar-Apr; 32(2):251-5.
    View in: PubMed
    Score: 0.473
  9. When killers become helpers. Sci Transl Med. 2013 Jul 24; 5(195):195fs29.
    View in: PubMed
    Score: 0.451
  10. Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice. Am J Kidney Dis. 2011 Mar; 57(3):498-507.
    View in: PubMed
    Score: 0.378
  11. Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function. J Oral Pathol Med. 2009 Jan; 38(1):42-7.
    View in: PubMed
    Score: 0.329
  12. Pulmonary Involvement in a Mouse Model of Sjögren's Syndrome Induced by STING Activation. Int J Mol Sci. 2020 Jun 25; 21(12).
    View in: PubMed
    Score: 0.182
  13. Hyperglycemia and Salivary Gland Dysfunction in the Non-obese Diabetic Mouse: Caveats for Preclinical Studies in Sjögren's Syndrome. Sci Rep. 2019 11 29; 9(1):17969.
    View in: PubMed
    Score: 0.175
  14. Immune Response Targeting Sjögren's Syndrome Antigen Ro52 Suppresses Tear Production in Female Mice. Int J Mol Sci. 2018 Sep 27; 19(10).
    View in: PubMed
    Score: 0.161
  15. Activation of Stimulator of Interferon Genes (STING) and Sjögren Syndrome. J Dent Res. 2018 07; 97(8):893-900.
    View in: PubMed
    Score: 0.155
  16. Immune response against the coiled coil domain of Sjögren's syndrome associated autoantigen Ro52 induces salivary gland dysfunction. Clin Exp Rheumatol. 2018 May-Jun; 36 Suppl 112(3):41-46.
    View in: PubMed
    Score: 0.154
  17. Brief Report: Patients With Primary Sjögren's Syndrome Who Are Positive for Autoantibodies to Tripartite Motif-Containing Protein 38 Show Greater Disease Severity. Arthritis Rheumatol. 2016 Mar; 68(3):724-9.
    View in: PubMed
    Score: 0.135
  18. Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice. Ann Rheum Dis. 2016 Mar; 75(3):617-22.
    View in: PubMed
    Score: 0.125
  19. Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease. Nephron Exp Nephrol. 2014; 126(3):141-7.
    View in: PubMed
    Score: 0.119
  20. T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol. 2014 May-Jun; 152(1-2):1-9.
    View in: PubMed
    Score: 0.117
  21. Type I interferon receptor deficiency prevents murine Sjogren's syndrome. J Dent Res. 2013 May; 92(5):444-9.
    View in: PubMed
    Score: 0.110
  22. Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis. Nephron Exp Nephrol. 2012; 121(1-2):e1-9.
    View in: PubMed
    Score: 0.107
  23. Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling. J Oral Pathol Med. 2013 Jan; 42(1):66-72.
    View in: PubMed
    Score: 0.104
  24. Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease. Oral Dis. 2011 Nov; 17(8):801-7.
    View in: PubMed
    Score: 0.098
  25. Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease. Am J Pathol. 2011 Aug; 179(2):651-60.
    View in: PubMed
    Score: 0.097
  26. Mesangial pathology in glomerular disease: targets for therapeutic intervention. Adv Drug Deliv Rev. 2010 Nov 30; 62(14):1337-43.
    View in: PubMed
    Score: 0.092
  27. Genetic complementation results in augmented autoantibody responses to lupus-associated antigens. J Immunol. 2009 Sep 01; 183(5):3505-11.
    View in: PubMed
    Score: 0.086
  28. Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus. Arthritis Rheum. 2008 Dec; 58(12):3884-91.
    View in: PubMed
    Score: 0.082
  29. Inflammatory stimuli accelerate Sjögren's syndrome-like disease in (NZB x NZW)F1 mice. Arthritis Rheum. 2008 May; 58(5):1318-23.
    View in: PubMed
    Score: 0.078
  30. A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading. J Immunol. 2007 Feb 15; 178(4):2565-71.
    View in: PubMed
    Score: 0.072
  31. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol. 2006 Dec 01; 177(11):8258-65.
    View in: PubMed
    Score: 0.071
  32. Role of anti-DNA antibodies in the pathogenesis of lupus nephritis. Autoimmun Rev. 2006 Jul; 5(6):414-8.
    View in: PubMed
    Score: 0.066
  33. Epitope spreading within lupus-associated ribonucleoprotein antigens. Clin Immunol. 2005 Nov; 117(2):112-20.
    View in: PubMed
    Score: 0.065
  34. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand J Immunol. 2004 Jul-Aug; 60(1-2):52-63.
    View in: PubMed
    Score: 0.060
  35. Single Cell Transcriptomics Implicate Novel Monocyte and T Cell Immune Dysregulation in Sarcoidosis. Front Immunol. 2020; 11:567342.
    View in: PubMed
    Score: 0.047
  36. Anti-La positive, anti-Ro negative subset of primary Sjögren's syndrome: anti-La is a reality but is the disease? Clin Exp Rheumatol. 2017 May-Jun; 35(3):438-444.
    View in: PubMed
    Score: 0.036
  37. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J Immunol. 2010 Jan 15; 184(2):1085-91.
    View in: PubMed
    Score: 0.022
  38. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med. 2004 Jan 19; 199(2):255-64.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.